CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Community Reinforcement Approachbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00376558
NCT00376558N/ACompleted
CompareCT.gov

Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence

New York State Psychiatric Institute·interventional·Posted Sep 15, 2006·Updated Jul 1, 2016

In Brief

A clinical study evaluating Community Reinforcement Approach for Cocaine Dependence. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether patients with the greatest loss of dopamine transmission due to cocaine dependence at pre-treatment PET and MRI scans will be those who fail to respond to substance abuse treatment. This study will also determine whether patients who do respond to treatment will experience a recovery of dopamine function. This study includes free brain imaging and behavioral intervention. Compensation provided for the brain scans.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2006
Enrollment StartJul 1, 2006
Primary CompletionJul 1, 2010
Study CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 19.8 years ago

Interventions

Community Reinforcement Approachbehavioral

Community Reinforcement Approach (CRA): The community reinforcement treatment program will be carried out in accordance with NIDA's therapy manual (13).During weeks 13 through 24, patients will meet once per week with their therapists. Sessions will focus on promoting continued change in the life areas addressed in the first 12 weeks of treatment or new components are added as needed.